Effects of a fixed combination of losartan with hydrochlorothiazide on glucose tolerance in hypertensive patients uncontrolled with angiotensin II receptor blockers alone

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 3, 2013, Pages 238-244

  Yamamuro, Megumi ^a   Yamamoto, Koichiro ^b   Kan, Hirofumi ^c   Takashio, Seiji ^a   Tayama, Shinji ^a   Kaikita, Koichi ^a   Hokimoto, Seiji ^a   Sumida, Hitoshi ^a   Sugiyama, Seigo ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Nishinihon Hospital   (Japan)

^c Kan Kaimeido Clinic   (Japan)

Author keywords

Angiotensin II receptor blocker; Glucose tolerance; Hydrochlorothiazide; Hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; CALCIUM ANTAGONIST; CANDESARTAN; CREATININE; ELECTROLYTE; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOSARTAN; OLMESARTAN; PROTON PUMP INHIBITOR; TELMISARTAN; URIC ACID; VALSARTAN; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMAN; INSULIN RESISTANCE; MALE; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; DRUG COMBINATIONS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED;

EID: 84875384808     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14464     Document Type: Article

References (29)

1. Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A; Asia Pacific Cohort Studies Collaboration: Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension, 2003; 42: 69-75
2. Lawes CM, Bennett DA, Feigin VL, Rodgers A: Blood pressure and stroke: an overview of published reviews. Stroke, 2004; 35: 1024
3. Lida M, Ueda K, Okayama A, Kodama K, Sawai K, Shibata S, Tanaka S, Keijnkai T, Horibe H, Minowa M, Yanagawa H, Hashimoto T; Nippon Data 80 Research Group: Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese--Nippon data 80. J Hum Hypertens, 2003; 17: 851-857
4. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke, 2000; 31: 2616-2622
5. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res, 2009; 32: 3-107
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007; 25: 1105-1187
7. Mochizuki S, Dahlöf B, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, Ohta M, Yamada T, Ogawa K, Kanae K, Kawai M, Seki S, Okazaki F, Taniguchi M, Yoshida S, Tajima N; Jikei Heart Study group: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet, 2007; 369: 1431-1439
8. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D: Losartan, an Angiotensin Type 1 Receptor Antagonist, Improves Endothelial Function in Non-Insulin-Dependent Diabetes. J Am Coll Cardiol, 2000; 36: 1461-1466
9. Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb, 2009; 16: 621-626
10. Hitsumoto T, Takahashi M, Iizuka T, Shirai K: Effect of the angiotensin II receptor antagonist telmisartan on lipoprotein lipase mass in preheparin serum. J Atheroscler Thromb, 2008; 15: 138-145
11. Sato Y, Fujii S, Imagawa S, Ohmura K, Ohmura Y, Andoh Y, Dong J, Ishimori N, Furumoto T, Tsutsui H: Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers. J Atheroscler Thromb, 2007; 14: 31-35
12. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL: Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension, 2006; 48: 219-224
13. Kita T, Yokota N, Ichiki Y, Ayabe T, Etoh T, Tamaki N, Kato J, Eto T, Kitamura K: One-year effectiveness and safety of open-label losartan/hydrochlorothiazidecombination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE Inhibitors. Hypertens Res, 2010; 33: 320-325
14. Kamura A, Inoue T, Kuroki S, Ishida S, Iimori K, Kato T, Naitoh H, Tamesue S, Ikeda H, Node K: Antihypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients' quality of life: The Saga Challenge Antihypertensive Study (S-CATS). Hypertens Res, 2011; 34: 1288-1294
15. Ito H, Ishii K, Kihara H, Kasayuki N, Nakamura F, Shimada K, Fukuda S, Iwakura K, Yoshikawa J; Effect of ARB/Diuretics on Diastolic Function in Patients with Hypertension (EDEN) trial investigators. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and Improves heart failure in patients with hypertension. Hypertens Res, 2012; 35: 93-99
16. Jensterle M, Sebestjen M, Janez A, Prezelj J, Kocjan T, Keber I, Pfeifer M: Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome. Eur J Endocrinol, 2008; 159: 399-406
17. Matsuda M, De Fronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care, 1999: 22: 1462-1470
18. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group: Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE); a randomized trial against atenolol. Lancet, 2002; 359: 995-1003
19. Hirose H, Kawabe H, Saito I: Effects of losartan/hydrochlorothiazide treatment, after change from ARB at usual dosage, on blood pressure and various metabolic parameters including high-molecular weight adiponectin in Japanese male hypertensive subjects. Clin Exp Hypertens, 2011; 33: 41-46
20. Racine N, Hamet P, Sampalis JS, Longo N, Bastien N: A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome. J Hum Hypertens, 2010; 24: 739-748
21. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y; Ohasama Study: How many times should blood pressure be measured at home for better prediction of stroke risk? Tenyear follow-up results from the Ohasama study. J Hypertens, 2004; 22: 1099-104
22. Agrawal RP, Sharma P, Gafoorunissa SJ, Ibrahim SA, Shah B, Shukla DK, Kaur T: Effect of camel milk on glucose metabolism in adults with normal glucose tolerance and type 2 diabetes in Raica community: a crossover study. Acta Biomed, 2011; 82: 181-186
23. Shen D-C, Shieh S-M, Fuh MM-T, Wu D-A, Chen Y-DI, Reaven GM: Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab, 1988; 66: 580-583
24. Reaven GM: Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: parallels between human disease and rodent models. Diabetes Care, 1991; 14: 195-202
25. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med, 1996; 334: 374-381
26. Bakris G, Molitch M, Hewkin A, Kipnes M, Sarafidis P, Fakouhi K, Bacher P, Sowers J; STAR Investigators: Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care, 2006; 29: 2592-2597
27. Cooper-DeHoff RM, Wen S, Beitelshees AL, Zineh I, Gums JG, Turner ST, Gong Y, Hall K, Parekh V, Chapman AB, Boerwinkle E, Johnson JA: Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications. Hypertension, 2010; 55: 61-68
28. Ziegler MG, Lernhardt E, Solt-Buzsaki V: Dose response to hydrochlorothiazide in hypertensives receiving a calcium channel blocker. Clin Exp Hypertens A, 1988; 10: 791-800
29. Rosa TT, Palatini P: Clinical value of microalbuminuria in hypertension. J Hypertens, 2000; 18: 645-654